Navigation Links
NuVasive to Present at the Oppenheimer 20th Annual Healthcare Conference
Date:10/29/2009

SAN DIEGO, Oct. 29 /PRNewswire-FirstCall/ -- NuVasive, Inc. (Nasdaq: NUVA), a medical device company focused on developing products for minimally disruptive surgical treatments for the spine, announced today that Kevin O'Boyle, Chief Financial Officer and Executive Vice President, will present at the Oppenheimer 20th Annual Healthcare Conference at The Waldorf Astoria Hotel in New York, New York, on Tuesday, November 3, 2009.

A live webcast of the presentation will be available online from the investor relations page of the Company's corporate website at www.nuvasive.com. After the live webcast, the presentation will remain available on the website for 30 days.

About NuVasive

NuVasive is a medical device company focused on the design, development, and marketing of products for the surgical treatment of spine disorders. The Company's product portfolio is focused primarily on the $4.6 billion U.S. spine implant market. Additionally, the Company has expanded into the $1.5 billion global biologics market, the $1.5 billion international market, and is developing products for the emerging motion preservation market.

NuVasive's principal product offering is based on its Maximum Access Surgery, or MAS® platform. The MAS platform combines four categories of products that collectively minimize soft tissue disruption during spine surgery with maximum visualization and safe, easy reproducibility for the surgeon: NeuroVision®, a proprietary software-driven nerve avoidance system; MaXcess®, a unique split-blade retractor system; a wide variety of specialized implants; and several biologic fusion enhancers. MAS significantly reduces surgery time and returns patients to activities of daily living much faster than conventional approaches. Having redefined spine surgery with the MAS platform's later
'/>"/>

SOURCE NuVasive, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. NuVasive Announces Conference Call and Webcast of Third Quarter 2009 Results
2. NuVasive to Present at the JMP Securities Healthcare Focus Conference
3. Additional Data from the Qnexa Phase 3 Studies Presented at The Obesity Society 27th Annual Scientific Meeting
4. BioCryst to Present at Oppenheimer Healthcare Conference
5. Shire to Present Important Study Findings on its ADHD Treatments at a Major Psychiatric Meeting on October 29 and 30
6. Bayer and Onyx Announce Nexavar Data Presentations at 60th American Association for the Study of Liver Diseases Annual Meeting
7. Presentations of Cempra Pharmaceuticals CEM-102 (fusidic acid) at the Infectious Diseases Society of America Annual Meeting Highlight Properties That Make It an Excellent Anti-MRSA Candidate
8. Data Presented on Cempra Pharmaceuticals CEM-101 at the Infectious Diseases Society of America Annual Meeting Reinforces Potency and Coverage Against Multidrug-Resistant S. Pneumoniae Isolates
9. Cadence Pharmaceuticals CEO Ted Schroeder To Present at the Oppenheimer 20th Annual Healthcare Conference in New York City on November 4, 2009
10. Anadys Pharmaceuticals to Present at the Oppenheimer Healthcare Conference
11. Rigel Announces Presentations at Two Investor Conferences

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)...irstCall/ -- Unilens Vision Inc. (OTC Bulletin Boa...ops, licenses, manufactures, distributes and marke...erating results for the first quarter ended Septem...oyalty income, were $1,683,673 in the FY2010 first...e previous year first quarter (FY2009). The decre...
(Date:11/20/2009)...e-FirstCall/ -- Landauer, Inc. ( LDR) , will ...arter and full year of 2009 pre-market on Tuesday,...onference call for investors on Tuesday, December ...access the live call by dialing 877-941-9205 (with...(international callers), or by visiting the "Inves...
(Date:11/20/2009).../ -- Reportlinker.com announces that a new market ..., Blood Pressure Monitoring & Measurement In...//www.reportlinker.com/p0164309/Blood-Pressure-Mon...Analysis.html#utm_source=prnewswire&utm_medium...t of blood pressure is not only an indicator of ca...
Breaking Medicine Technology:Unilens Vision Reports Record First Quarter Earnings and Royalty Income 2Unilens Vision Reports Record First Quarter Earnings and Royalty Income 3Unilens Vision Reports Record First Quarter Earnings and Royalty Income 4Landauer, Inc. Sets Date and Time for Announcement of Fiscal Fourth Quarter and Full Year 2009 Results 2Reportlinker Adds Blood Pressure Monitoring & Measurement Instruments - A World Market Analysis 2Reportlinker Adds Blood Pressure Monitoring & Measurement Instruments - A World Market Analysis 3Reportlinker Adds Blood Pressure Monitoring & Measurement Instruments - A World Market Analysis 4Reportlinker Adds Blood Pressure Monitoring & Measurement Instruments - A World Market Analysis 5Reportlinker Adds Blood Pressure Monitoring & Measurement Instruments - A World Market Analysis 6Reportlinker Adds Blood Pressure Monitoring & Measurement Instruments - A World Market Analysis 7Reportlinker Adds Blood Pressure Monitoring & Measurement Instruments - A World Market Analysis 8Reportlinker Adds Blood Pressure Monitoring & Measurement Instruments - A World Market Analysis 9Viles 26 Beckman LLC 3A Stop Your Headache NOT Your Liver 50688 1Viles 26 Beckman LLC 3A Stop Your Headache NOT Your Liver 50688 2Cancer Endangers Some Wildlife Species 50683 1Cancer Endangers Some Wildlife Species 50683 2 28RED 29ZONES Launch at First U2 360 Degrees Concert in Barcelona 50678 1 28RED 29ZONES Launch at First U2 360 Degrees Concert in Barcelona 50678 2 28RED 29ZONES Launch at First U2 360 Degrees Concert in Barcelona 50678 3
...6 Results from RESTORE 2, a,placebo-controlled, P...al,compound retigabine significantly reduced the n...y partial-onset epilepsy when a 600 mg or 900 mg d...c drug (AED) therapy. Prior to,enrollment in the r...ing,seizures despite taking stable doses of up to ...
... Dec. 6 Researchers today report that after the i... erythropoiesis-stimulating agents (ESAs), a signi...nts who were on chemotherapy and who received ESAs... of blood per patient than those patients who rece...tations. The findings from this observational stu...
Other Medicine Technology:Retigabine Significantly Reduces the Number of Seizures in Adults With Inadequately Controlled Partial-Onset Epilepsy 2Retigabine Significantly Reduces the Number of Seizures in Adults With Inadequately Controlled Partial-Onset Epilepsy 3Retigabine Significantly Reduces the Number of Seizures in Adults With Inadequately Controlled Partial-Onset Epilepsy 4Retigabine Significantly Reduces the Number of Seizures in Adults With Inadequately Controlled Partial-Onset Epilepsy 5Observational Study Finds Changes in Medicare Reimbursement for Erythropoiesis-Stimulating Agents Associated With Increased Need for Blood Transfusion 2Observational Study Finds Changes in Medicare Reimbursement for Erythropoiesis-Stimulating Agents Associated With Increased Need for Blood Transfusion 3Observational Study Finds Changes in Medicare Reimbursement for Erythropoiesis-Stimulating Agents Associated With Increased Need for Blood Transfusion 4Observational Study Finds Changes in Medicare Reimbursement for Erythropoiesis-Stimulating Agents Associated With Increased Need for Blood Transfusion 5Observational Study Finds Changes in Medicare Reimbursement for Erythropoiesis-Stimulating Agents Associated With Increased Need for Blood Transfusion 6
(Date:11/23/2009)... 23, 2009 In the November issue of GIE: Gastroin...entific journal of the American Society for Gastro...rd University found that Barrett,s esophagus was d...going endoscopic screening. Also in this issue, tw...searchers from France, in the largest single-cente...
(Date:11/23/2009)...used by the build-up of a brain peptide called amy...been the focus of almost all drug research pursuin...dition. , But that may be counterproductive, say...ment of Physiology and Pharmacology, Sackler Facul...hat amyloid-beta is also necessary to maintain pro...
(Date:11/23/2009)...wswire-FirstCall/--AnnTaylorStoresCorp.announcedto...hannualThanksandGivingcampaign,aholidayfundraising...pital.ThisyearmarksthethirdyearthatAnnTaylor,throu...patedinthecampaignwhereweofferourshoppersanopportu...ileshoppingthisholidayseason.ClientswhoshopatAnnTa...
(Date:11/23/2009)...ansplants need longer-term support than most frien...lise, according to a study of 160 patients publish...of Advanced Nursing . , Researchers surveyed... year, together with 105 who had had surgery in th...lant Center in Tennessee, USA. They wanted to see ...
(Date:11/23/2009)...n may improve patient outcomes, research suggests ...A new combination drug therapy shows promise in tr...s, researchers say. , The study from the Massac...ound that survival and tumor response in patients ...s inhibitor that has helped slow the growth of oth...
Breaking Medicine News(10 mins):Health News:Study highlights from November issue of GIE: Gastrointestinal Endoscopy 2Health News:Study highlights from November issue of GIE: Gastrointestinal Endoscopy 3Health News:Study highlights from November issue of GIE: Gastrointestinal Endoscopy 4Health News:Study highlights from November issue of GIE: Gastrointestinal Endoscopy 5Health News:Upending textbook science on Alzheimer's disease 2Health News:Ann Taylor Stores Corp. Returns To St. Jude Children's Research Hospital's Thanks and Giving Campaign(R) For The Third Year 2Health News:Drug side effects a key factor in reduced quality of life for kidney transplant patients 2Health News:Drug side effects a key factor in reduced quality of life for kidney transplant patients 3Health News:Combo Treatment Beneficial in Biliary-Tract Cancer Study 2
...on to,Protect Florida,s Drivers praised Governor C...him for expanding the call of this week,s special,...lt expired at midnight,today. Saying that Persona...vers and their passengers, Governor,Crist encourag...
...nnounced,that it has successfully emerged from cha...onths after filing for bankruptcy protection on Ju...by Harbinger Capital Partners,Master Fund I, Ltd. ...exchange for 100% of,the common equity of reorgani...
..., 2007, WASHINGTON, Oct. 1 The following is bein...benow, D-Michigan Rep. Emmanuel Cleaver, D-Missou...ev. Jim Wallis, Executive Director of Sojourners a... Social Justice Lobby Father Ray East - Executive...
...d public entities in the addiction treatment field...nges to Improve Outcomes Now (ACTION) Campaign for...The ACTION Campaign goals are to increase access t...eptember, has a goal of improving the lives of 55,...
...n,(Nasdaq: AIRM ), the largest air medical transp...t the Company has completed its acquisition of,100...gs, Inc. (parent,company of CJ Systems Aviation Gr... and was primarily,financed through a new five-yea...
...if given with 24 hours, study finds , , ...sed to treat severe acne and urinary tract infecti...te ischemic stroke, a new report from Israeli rese...rts say. , Though it is too early to change patien...
Other Medicine News:Health News:Coalition to Protect Florida's Drivers Applauds Governor Crist for Adding PIP to Special Session 2Health News:Bally Total Fitness Emerges From Chapter 11 and Closes Transaction with Harbinger Capital Partners Funds 2Health News:Bally Total Fitness Emerges From Chapter 11 and Closes Transaction with Harbinger Capital Partners Funds 3Health News:Leaders in addiction treatment announce national 'ACTION' campaign 2Health News:Air Methods Completes Acquisition of FSS Airholdings, Inc., Parent Company of CJ Systems Aviation Group, Inc. 2Health News:Antibiotic Shows Promise as Stroke Treatment 2Health News:Antibiotic Shows Promise as Stroke Treatment 3
...a compact RFID printing solution that can encode s...er/encoder is one of the most versatile in the ind...dia such as wristbands and smart labels, the R2844...er processing speed and more connectivity choices-...
HealthTrax Asset Tracking Software
...designed to protect a wandering resident from leav...ured. Such residents typically have been diagnosed... a head injury., At-risk residents wear a small W...nd points of exit are discreetly secured by WatchM...
PDC Smart™ Label
Medicine Products: